日韩精品久久一区二区三区_亚洲色图p_亚洲综合在线最大成人_国产中出在线观看_日韩免费_亚洲综合在线一区

Global EditionASIA 中文雙語Fran?ais
World
Home / World / Americas

US FDA issues emergency use authorization for first COVID-19 vaccine

Xinhua | Updated: 2020-12-12 14:08
Share
Share - WeChat
In this file photo illustration taken on Nov 23, 2020, shows a syringe and a bottle reading "COVID-19 Vaccine" next to the Pfizer company logo. [Photo/Agencies]

WASHINGTON -- The US Food and Drug Administration (FDA) Friday issued authorization for emergency use of the first COVID-19 vaccine in the United States.

The first Emergency Use Authorization (EUA) was issued to the COVID-19 vaccine of American drugmaker Pfizer in partnership with German company BioNTech, allowing the vaccine to be distributed in the United States.

The FDA has determined that Pfizer-BioNTech COVID-19 vaccine has met the statutory criteria for issuance of an EUA. The totality of the available data provides clear evidence that Pfizer-BioNTech COVID-19 vaccine may be effective in preventing COVID-19, said the FDA in a statement.

The data also show that the known and potential benefits outweigh the known and potential risks, supporting the vaccine's use in millions of people 16 years of age and older, said the FDA.

"The FDA's authorization for emergency use of the first COVID-19 vaccine is a significant milestone in battling this devastating pandemic that has affected so many families in the United States and around the world," said FDA Commissioner Stephen Hahn.

"Today's action follows an open and transparent review process that included input from independent scientific and public health experts and a thorough evaluation by the agency's career scientists to ensure this vaccine met FDA's rigorous, scientific standards for safety, effectiveness, and manufacturing quality needed to support emergency use authorization," he said in a statement.

The Pfizer-BioNTech vaccine contains a small piece of the SARS-CoV-2 virus's mRNA that instructs cells in the body to make the virus's distinctive "spike" protein.

When a person receives this vaccine, their body produces copies of the spike protein, which does not cause disease, but triggers the immune system to learn to react defensively, producing an immune response against SARS-CoV-2.

The vaccine is administered as a series of two doses, three weeks apart.

Global COVID-19 cases surpassed 70 million on Friday, according to the Center for Systems Science and Engineering at Johns Hopkins University. The United States reported the most cases and deaths around the world as of 4:28 pm local time (2128 GMT), numbering 15,758,661 and 293,785, respectively.

Most Viewed in 24 Hours
Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
主站蜘蛛池模板: 国产一区二区精品丝袜 | 国产极品久久 | 黄色免费在线观看网址 | 亚洲 欧美 日韩 在线 香蕉 | 日本黄视频在线观看 | 99热久久这里只精品国产 | 久久精品人人做人人看最新章 | 免费国产午夜在线观看 | 精品亚洲综合在线第一区 | 日韩欧美精品综合一区二区三区 | 精品久久 | 成人久久久| 日本黄色免费看 | 久久久久无码国产精品一区 | 99久久中文字幕伊人 | 欧美高清成人 | 欧美日韩视频在线播放 | 国产激情91久久精品导航 | 国产高清美女一级a毛片久久 | 91久色视频| 欧美午夜一艳片欧美精品 | 国内外一级毛片 | 欧美视频在线第一页 | 成人一区二区在线观看视频 | 青青在线香蕉精品视频免费看 | 天天躁夜夜躁很很躁麻豆 | 欧美精品无需播放器在线观看 | 毛片免费看电影 | 亚洲精品国偷拍自产在线观看蜜桃 | 欧美video| 91香蕉国产视频 | 污网站观看 | 亚洲va国产va | 99热这里有精品 | 国产精品婷婷午夜在线观看 | 国产免费网址 | 天天做天天爱夜夜爽女人爽宅 | 色视频在线观看 | 日本永久视频 | 日产一一到六区麻豆 | 久久国产成人 |